Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viveka Frykman

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|August 2, 2018
Usefulness of Short-Lasting Episodes of Supraventricular Arrhythmia (Micro-Atrial Fibrillation) as a Risk Factor for Atrial FibrillationTove Fredriksson, Viveka Frykman, Leif Friberg, et al.
European Heart Journal|May 28, 2011
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculAMattias Wieloch, Anders Själander, Viveka Frykman, et al.
Lancet (London, England)|September 1, 2021
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trialEmma Svennberg, Leif Friberg, Viveka Frykman, et al.
Pacing and Clinical Electrophysiology : PACE|August 14, 2003
Rapid atrial pacing does not decrease the atrial defibrillation thresholdViveka Frykman, Borje Darpo, Gregory M Ayers, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 14, 2012
Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)Leif Friberg, Johan Engdahl, Viveka Frykman, et al.
Circulation|April 26, 2015
Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP StudyEmma Svennberg, Johan Engdahl, Faris Al-Khalili, et al.
Heart (British Cardiac Society)|March 4, 2017
N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillationEmma Svennberg, Peter Henriksson, Johan Engdahl, et al.
Environmental Epidemiology (Philadelphia, Pa.)|August 17, 2022
Short-term ambient air pollution exposure and risk of atrial fibrillation in patients with intracardiac devicesMarcus Dahlquist, Viveka Frykman, Massimo Stafoggia, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillationEmma Svennberg, Martin Stridh, Johan Engdahl, et al.
Preventive Medicine|October 2, 2022
Factors predicting participation and potential yield of screening-detected disease among non-participants in a Swedish population-based atrial fibrillation screening studyKatrin Kemp Gudmundsdottir, Carl Bonander, Tove Hygrell, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|August 2, 2018
Usefulness of Short-Lasting Episodes of Supraventricular Arrhythmia (Micro-Atrial Fibrillation) as a Risk Factor for Atrial FibrillationTove Fredriksson, Viveka Frykman, Leif Friberg, et al.
European Heart Journal|May 28, 2011
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculAMattias Wieloch, Anders Själander, Viveka Frykman, et al.
Lancet (London, England)|September 1, 2021
Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trialEmma Svennberg, Leif Friberg, Viveka Frykman, et al.
Pacing and Clinical Electrophysiology : PACE|August 14, 2003
Rapid atrial pacing does not decrease the atrial defibrillation thresholdViveka Frykman, Borje Darpo, Gregory M Ayers, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 14, 2012
Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)Leif Friberg, Johan Engdahl, Viveka Frykman, et al.
Circulation|April 26, 2015
Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP StudyEmma Svennberg, Johan Engdahl, Faris Al-Khalili, et al.
Heart (British Cardiac Society)|March 4, 2017
N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillationEmma Svennberg, Peter Henriksson, Johan Engdahl, et al.
Environmental Epidemiology (Philadelphia, Pa.)|August 17, 2022
Short-term ambient air pollution exposure and risk of atrial fibrillation in patients with intracardiac devicesMarcus Dahlquist, Viveka Frykman, Massimo Stafoggia, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2017
Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillationEmma Svennberg, Martin Stridh, Johan Engdahl, et al.
Preventive Medicine|October 2, 2022
Factors predicting participation and potential yield of screening-detected disease among non-participants in a Swedish population-based atrial fibrillation screening studyKatrin Kemp Gudmundsdottir, Carl Bonander, Tove Hygrell, et al.
Pageof 6